
PathWhiz ID | Pathway | Meta Data |
---|---|---|
PW000325 |
drug action
Chlorothiazide Action PathwayHomo sapiens
Chlorothiazide (also known as Diuril) is an organic compound that used for diuretic. It can inhibit the solute carrier family 12 member 3 (also known as sodium-chloride symporter) in the nephron to prevent water reabsorption. Solute carrier family 12 member 3 is also used for sodium reabsorption that count for 5% of total amount. Solute carrier family 12 member 3 transports chloride and sodium from lumen to epithelial cell, and sodium/potassium ATPases facilitate the export of sodium to basolateral interstitium to provide sodium gradient that will increase the osmolarity in interstitium, which lead to establishment of osmotic gradient for water reabsorption.
|
Creator: WishartLab Created On: August 22, 2013 at 10:45 Last Updated: August 22, 2013 at 10:45 |
PW132394 |
Chlorothiazide Drug MetabolismHomo sapiens
Chlorothiazide is a drug that is not metabolized by the human body as determined by current research and biotransformer analysis. Chlorothiazide passes through the liver and is then excreted from the body mainly through the kidney.
|
Creator: Ray Kruger Created On: September 21, 2023 at 21:26 Last Updated: September 21, 2023 at 21:26 |
PW144983 |
drug action
Chlorothiazide Drug Metabolism Action PathwayHomo sapiens
|
Creator: Ray Kruger Created On: October 07, 2023 at 14:51 Last Updated: October 07, 2023 at 14:51 |
PW145329 |
drug action
Chloroxine Drug Metabolism Action PathwayHomo sapiens
|
Creator: Ray Kruger Created On: October 07, 2023 at 15:34 Last Updated: October 07, 2023 at 15:34 |
PW146245 |
drug action
Chloroxylenol Drug Metabolism Action PathwayHomo sapiens
|
Creator: Ray Kruger Created On: October 07, 2023 at 17:46 Last Updated: October 07, 2023 at 17:46 |
PW057579 |
drug action
Chlorphenamine H1-Antihistamine ActionHomo sapiens
Chlorphenamine (chlorpheniramine) is a first-generation alkylamine H1-antihistamine. H1-antihistamines interfere with the agonist action of histamine at the H1 receptor and are administered to attenuate inflammatory process in order to treat conditions such as allergic rhinitis, allergic conjunctivitis, and urticaria. Reducing the activity of the NF-κB immune response transcription factor through the phospholipase C and the phosphatidylinositol (PIP2) signalling pathways also decreases antigen presentation and the expression of pro-inflammatory cytokines, cell adhesion molecules, and chemotactic factors. Furthermore, lowering calcium ion concentration leads to increased mast cell stability which reduces further histamine release. First-generation antihistamines readily cross the blood-brain barrier and cause sedation and other adverse central nervous system (CNS) effects (e.g. nervousness and insomnia). Second-generation antihistamines are more selective for H1-receptors of the peripheral nervous system (PNS) and do not cross the blood-brain barrier. Consequently, these newer drugs elicit fewer adverse drug reactions.
|
Creator: Carin Li Created On: September 14, 2017 at 15:36 Last Updated: September 14, 2017 at 15:36 |
PW146872 |
drug action
Chlorphenesin carbamate Drug Metabolism Action PathwayHomo sapiens
|
Creator: Ray Kruger Created On: October 07, 2023 at 19:15 Last Updated: October 07, 2023 at 19:15 |
PW176427 |
Chlorphenesin carbamate Predicted Metabolism PathwayHomo sapiens
Metabolites of Template3MB4 are predicted with biotransformer.
|
Creator: Omolola Created On: December 08, 2023 at 15:11 Last Updated: December 08, 2023 at 15:11 |
PW144961 |
drug action
Chlorphenesin Drug Metabolism Action PathwayHomo sapiens
|
Creator: Ray Kruger Created On: October 07, 2023 at 14:48 Last Updated: October 07, 2023 at 14:48 |
PW176455 |
Chlorphenesin Predicted Metabolism PathwayHomo sapiens
Metabolites of Chlorphenesin are predicted with biotransformer.
|
Creator: Omolola Created On: December 12, 2023 at 14:42 Last Updated: December 12, 2023 at 14:42 |